Marina Ramirez-Alvarado, PhD, Mayo Clinic, Rochester, MN, emphasizes the importance of early diagnosis in systemic amyloidosis and outlines strategies to achieve that, including detection of early organ dysfunction and detection of light chain glycosylation. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.